[MHC class I deficiency].
Morio
T
T
Division of Human Ontogeny and Childhood Development, Graduate School, Tokyo Medical and Dental University.
D000071181:ATP Binding Cassette Transporter, Subfamily B, Member 2; D000071450:ATP Binding Cassette Transporter, Subfamily B, Member 3; D018528:ATP-Binding Cassette Transporters / Q000235:genetics; D000818:Animals; D017951:Antigen Presentation; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D003937:Diagnosis, Differential; D018380:Hematopoietic Stem Cell Transplantation; D015395:Histocompatibility Antigens Class I / Q000276:immunology; D006801:Humans; D007694:Killer Cells, Natural / Q000276:immunology; D009154:Mutation; D010455:Peptides / Q000378:metabolism; D011379:Prognosis; D016511:Severe Combined Immunodeficiency / Q000145:classification / Q000209:etiology
D000071181:ATP Binding Cassette Transporter, Subfamily B, Member 2; D000071450:ATP Binding Cassette Transporter, Subfamily B, Member 3; D018528:ATP-Binding Cassette Transporters; D015395:Histocompatibility Antigens Class I; D010455:Peptides; C073119:TAP1 protein, human; C071692:TAP2 protein, human